Back
Meritage Homes Vs. Novo Nordisk AS Industry Stock Comparison
Buy
63
MTH
Meritage Homes
Last Price:
$155.86
Seasonality Move:
1.86%
Sell
26
NVO
Novo Nordisk AS
Last Price:
$87.33
Seasonality Move:
6.58%
Buy
63
Meritage Homes (MTH)
is a Buy
Is Meritage Homes a Buy, Sell or Hold?
-
The current Meritage Homes [MTH] share price is $154.61. The Score for MTH is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
MTH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $88.71. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MTH Stock Price Chart
What is Meritage Homes's stock price today?
-
The Meritage Homes share price today is $154.61Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTH is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $88.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
MTH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -8.22 | Sell |
Relative Strength Index (14 RSI): | 28.05 | Sell |
Chaikin Money Flow: | 72701 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (164.75 - 189.93) | Sell |
Bollinger Bands (100): | (176.2 - 200.2) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.52 | Sell |
Relative Strength Index (14 RSI): | 27.28 | Sell |
Chaikin Money Flow: | 14079249 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (99.16 - 111.42) | Sell |
Bollinger Bands (100): | (106.53 - 131.27) | Sell |
MTH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 161.78 | Sell |
20-day SMA: | 176.87 | Sell |
50-day SMA: | 182.33 | Sell |
200-day SMA: | 179.15 | Sell |
8-day EMA: | 161.4 | Sell |
20-day EMA: | 171.2 | Sell |
50-day EMA: | 179.9 | Sell |
200-day EMA: | 177.08 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 101.84 | Sell |
20-day SMA: | 105.84 | Sell |
50-day SMA: | 108.65 | Sell |
200-day SMA: | 126.03 | Sell |
8-day EMA: | 99.1 | Sell |
20-day EMA: | 103.93 | Sell |
50-day EMA: | 109.19 | Sell |
200-day EMA: | 117.8 | Sell |
Meritage Homes Earnings Growth & MTH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.52 per share, and an increase next year of $0.08 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.
Meritage Homes Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |